Welcome
Support Centre
12 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ ...Back to search results ] [ Print-friendly version ]
Immediate management of patients with ruptured aneurysm: open versus endovascular repair
ISRCTN ISRCTN48334791
ClinicalTrials.gov identifier NCT00746122
Public title Immediate management of patients with ruptured aneurysm: open versus endovascular repair
Scientific title Can emergency endovascular aneurysm repair (eEVAR) reduce mortality from ruptured abdominal aortic aneurysm (AAA)?
Acronym IMPROVE
Serial number at source HTA 07/37/64
Study hypothesis Ruptured abdominal aortic aneurysm is the bursting of the main blood vessel of the body (the aorta) in the belly, which causes death in over 85% of cases. An attempt at open surgical repair is made in less than half of those who arrive at hospital alive and of those receiving surgical repair only half will be alive at 30 days.

It is possible that application of new minimally invasive technology (endovascular aneurysm repair [EVAR]) would greatly improve the number of patients alive at 30 days. However not all patients are anatomically suitable for endovascular repair.

The principal research question is, to be addressed in a randomised clinical trial is:
Can a strategy of preferential endovascular repair of ruptured abdominal aortic aneurysm, versus the current practice of open surgical repair, significantly reduce the 30 day mortality of this condition?

More details can be found at: http://www.hta.ac.uk/1776
Protocol can be found at: http://www.hta.ac.uk/protocols/200700370064.pdf
Lay summary
Ethics approval Approval pending from the following ethics committees as of 02/12/2008:
1. Berkshire Research Ethics Committee (ref: 08/H0505/173)
2. Scotland A Research Ethics Committee (ref: 08/MRE00/90)
Study design Randomised controlled multi-centre trial
Countries of recruitment United Kingdom
Disease/condition/study domain Abdominal aortic aneurysm
Participants - inclusion criteria 1. Both males and females, over the age of 50 years
2. Clinical suspicion of ruptured abdominal aortic aneurysm after review in Accident and Emergency (or other hospital unit)
Participants - exclusion criteria 1. Patients with known connective tissue disorders (e.g., Marfan syndrome) where endovascular repair may not be beneficial
2. Patients with known previous repair of an abdominal aortic aneurysm, because procedures either open or endovascular are likely to be very complex and there are no guidelines for anatomical restriction to repair
3. Deeply unconscious and moribund patients since the chances of recovery are minimal
Anticipated start date 01/04/2009
Anticipated end date 31/03/2013
Status of trial Ongoing
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 600
Interventions The patients will be randomised to a strategy of EVAR if anatomically suitable (EVAR first) or to the standard emergency open surgery.
Primary outcome measure(s) 30 day mortality
Secondary outcome measure(s) 1. Mortality at 24-hour, in-hospital, and 1-year after the rupture
2. Complications and re-interventions related to ruptured AAA repair in 1 year
3. Major morbidity (stroke, myocardial infarction, renal or respiratory failure) in 1 year
4. Accuracy of clinical diagnosis of ruptured abdominal aortic aneurysm
5. Cost-effectiveness
Sources of funding NIHR Health Technology Assessment Programme - HTA (UK)
Trial website
Publications 1. 2009 publication in http://www.ncbi.nlm.nih.gov/pubmed/19464199
2. 2009 protocol in http://www.ncbi.nlm.nih.gov/pubmed/20184048
Contact name Prof  Janet  Powell
  Address Vascular Surgery Research Group
Imperial College London
Charing Cross Campus
St Dunstans Road
  City/town London
  Zip/Postcode W6 8RP
  Country United Kingdom
  Tel +44 (0)20 8846 7312
  Email j.powell@imperial.ac.uk
Sponsor Imperial College London (UK)
  Address Research Governance Office
Faculty of Medicine
G02 Sir Alexander Flemming Building
South Kensington Campus
  City/town London
  Zip/Postcode SW7 2AZ
  Country United Kingdom
  Sponsor website: http://www3.imperial.ac.uk/
Date applied 02/12/2008
Last edited 09/03/2010
Date ISRCTN assigned 12/12/2008
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central